Form 4: Molina Healthcare CFO Mark Keim Reports Stock Transactions

Molina Healthcare's CFO, Mark Keim, reports acquisition and disposal of company stock related to performance stock units and restricted stock grants.

Summary

• Mark Keim, CFO of Molina Healthcare, reported several transactions involving the company's common stock on March 1, 2024.
• These transactions include the acquisition of 16,063 shares related to the settlement of performance stock units that vested at 170% achievement level based on the company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023.
• Additionally, 7,658 shares and 2,507 shares were applied to the payment of withholding taxes in connection with the vesting of performance stock units and other shares.
• Keim also acquired 5,165 shares of restricted stock under the company's 2019 Equity Incentive Plan.
• The reported transactions resulted in Keim beneficially owning 47,594 shares of Molina Healthcare common stock.
• Jeff D. Barlow, by power of attorney, signed the report on behalf of Mark Lowell Keim.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The vesting of performance stock units at 170% suggests the company exceeded its performance targets, which is a positive signal. The grant of restricted stock is a standard practice and doesn't necessarily indicate a strong positive or negative sentiment.

Positives

• The vesting of performance stock units at 170% suggests strong performance relative to targets.
• The grant of restricted stock aligns the CFO's interests with those of shareholders.

Future Outlook

The restricted stock vests in increments on March 1, 2025, March 1, 2026 and March 1, 2027.

Industry Context

Executive stock transactions are common and closely monitored as they can provide insights into management's confidence in the company's future prospects. Vesting of performance stock units tied to adjusted net income per share indicates a focus on profitability.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, bonus, stock options, and restricted stock units.
• Vesting schedules for restricted stock typically range from three to five years, aligning with industry norms.
• Performance-based equity awards, like the performance stock units in this case, are designed to incentivize executives to achieve specific financial or operational goals.
• Comparable companies in the healthcare sector, such as UnitedHealth Group (UNH) and Anthem (ANTM), also utilize similar equity-based compensation strategies.

Stakeholder Impact

• The vesting of performance stock units and grant of restricted stock can impact shareholder value depending on the company's future performance.
• Executive compensation practices are of interest to shareholders and can influence their perception of management's alignment with their interests.

Key Dates